Breast cancer cell lines: Friend or foe?

Breast Cancer Research

Volumn 5, Issue 2, 2003, Pages 89-95

  Burdall, Sarah E ^a,b   Hanby, Andrew M ^a   Lansdown, Mark R J ^b   Speirs, Valerie ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cell culture; In vitro models; Mammary gland

Indexed keywords

ANIMAL CELL; BREAST CANCER; BREAST TUMOR; CANCER CELL CULTURE; CANCER RESEARCH; CELL DIVISION; CELL GROWTH; CELL STRAIN MCF 7; CELL STRUCTURE; CELL SUBPOPULATION; CONTAMINATION; EXPERIMENTAL MODEL; EXPLANT; GENETIC DRIFT; GENOTYPE PHENOTYPE CORRELATION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFORMED CONSENT; KARYOTYPE; MEDICAL ETHICS; MEDICAL RESEARCH; NONHUMAN; REVIEW; TISSUE SLICE; TUMOR CELL CULTURE;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; HUMANS; QUALITY CONTROL; TUMOR CELLS, CULTURED;

EID: 0345700343     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr577     Document Type: Review

References (48)

1. Osborne CK, Hobbs K, Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat 1987, 9:111-121.
2. Bahia H, Ashman JNE, Cawkwell L, Lind M, Monson JRT, Drew PJ, Greenman J: Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int J Oncol 2002, 20:489-494.
3. Nelson-Rees WA, Daniels DW, Flandermeyer RR: Cross-contamination of cells in culture. Science 1981, 212: 446-452.
4. Gey GO, Coffman WD, Kubicek MT: Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952, 12:264-265.
5. MacLeod RAF, Dirks WG, Matsui Y, Kaufmannn M, Milch H, Drexler HG: Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 1999, 83:555-563.
6. Masters JRW: Human cancer cell lines: fact and fantasy. Nat Rev Mol Biol 2000, 1:233-236.
7. Masters JRW, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG: Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA 2001, 98:8012-8017.
8. Soule HD, Vasquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973, 51:1409-1413.
9. Ozzello L, Sordat B, Merenda C, Carrel S, Hurlimann J, Mach JP: Transplantation of a human mammary carcinoma cell line (BT 20) into nude mice. J Natl Cancer Inst 1974, 52:1669-1672.
10. Cailleau R, Young R, Olive M, Reeves WJ Jr: Breast tumour cell lines from pleural effusions. J Natl Cancer Inst 1974, 53:661-674.
11. Cailleau R, Olive M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978, 14:911-915.
12. Trempe GL: Human breast cancer in culture. Recent Results Cancer Res 1976, 57:33-41.
13. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 1979, 15:659-370.
14. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MB: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978, 38:3352-3364.
15. Ethier SP, Mahacek ML, Gullick WJ, Frank Tja ND, Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 1993, 53:627-635.
16. McCallum HM, Lowther GW: Long term culture of primary breast cancer in defined medium. Breast Cancer Res Treat 1996, 39:247-259.
17. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 1998, 78:766-774.
18. Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmandian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AF: Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res 1998, 4:23931-2938.
19. Freshney RI: Introduction to basic principles. In Animal Cell Culture: a Practical Approach. Edited by Freshney RI. Oxford: IRL Press; 1992:1-14.
20. Forozan F, Mahlamaki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden C, Ethier SP, Kallioiemi A, Kallioniemi O: Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000, 60:4519-4525.
21. Ethier SP, Kokeney KE, Ridings JW, Dilts CA: erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res 1996, 56:899-907.
22. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998, 21:177-184.
23. Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP: Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer 1999, 81:1328-1334.
24. Freshney RI: Induction of differentiation in neoplastic cells. Anticancer Res 1985, 5:111-130.
25. Lasfargues EY, Ozzello L: Cultivation of human breast carcinomas. J Natl Cancer Inst 1958, 21:1131-1147.
26. Dairkee SH, Deng G, Stampfer MR, Waldman FM, Smith HS: Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumour cells. Cancer Res 1997, 57:1590-1596.
27. Dairkee SH, Deng G, Stampfer MR, Waldman F, Smith HS: Selective culture of primary breast carcinoma. Cancer Res 1995, 55:2516-2519.
28. Speirs V, Green AR, White MC: Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Devel Biol 1996, 32:72-74.
29. Emerman JT, Wilkinson DA: Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples. In Vitro Cell Develop Biol 1990, 26:1186-1194.
30. Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ, Desai SB, Atkin SL: Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer 1998, 78:1421-1429.
31. Speirs V, Green AR, Atkin SL: Activity and expression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steroid Biochem Molec Biol 1998, 67:267-274.
32. Loveday RL, Speirs V, Drew PJ, Kerin MJ, Monson JR, Greenman J: Intracellular flow cytometric analysis of primary cultured breast tumour cells. Cancer Invest 2002, 20:340-347.
33. Wolman SR, Mohamed AN, Heppner GH, Soule HD: Chromosomal markers of immortalization in human breast epithelium. Genes Chromosomes Cancer 1994, 10:59-65.
34. Clarke C, Titley J, Davies S, O'Hare MJ: An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol 1994, 3:38-46.
35. Gudjonsson T, Villadsen R, Nielsen HK, Ronnov-Jessen, Bissell MJ, Petersen OW: Isolation, immortalisation, and characterisation of a human breast epithelial cell line with stem cell properties. Genes Devel 2002, 16:693-706.
36. Taylor-Papadimitrou J, Stampfer MS, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 1989, 94:403-413.
37. Ethier SP: Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia 1996, 1:111-121.
38. Imam SA, Kim MS, Anker L, Data RH, Law RE, Taylor CR: Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models. Anticancer Res 1997, 17:4435-4441.
39. Hood CJ, Parham DM: A simple method of tumour culture. Pathol Res Practice 1998, 194:177-181.
40. Biran S, Vlodavsky I, Fuks Z, Lijovetzky G, Horowitz AT: Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrix. Int J Cancer 1986, 38:345-354.
41. Bergstraesser LM, Weitzman SA: Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res 1993, 53:2644-2654.
42. Ip MM, Darcy KM: Three-dimensional mammary primary culture model systems. J Mammary Gland Biol Neoplasia 1996, 1:91-110.
43. Krasna L, Dudorkinova D, Vedralova J, Vesely P, Pokorna E, Kudlackova I, Chaloupkova A, Petruzelka L, Danes J, Matouskova E: Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours. Breast Cancer Res Treat 2002, 71:219-235.
44. The Report of The Royal Liverpool Children's Inquiry. [http://www.rlcinquiry.org.uk/].
45. Li Z, Bustos V, Miner j, Paulo E, Meng ZH, Zlotnikov G, Ljung B-M, Dairkee S: Propagation of genetically altered tumour cells derived from fine-needle aspirates of primary breast carcinoma. Cancer Res 1998, 58:5271-5274.
46. Fruehauf JP: In vitro assay-assisted treatment selection for women with breast or ovarian cancer. Endocr Relat Cancer 2002, 9:171-182.
47. Ellis RJ, Fabian CJ, Kimler BF, Tawfik O, Mayo MS, Decelis CR, Jewell WR, Connor C, Praeger M, McGinness M, Mehta R, Fruehauf JP: Factors associated with the success of the extreme drug resistance assay in primary breast cancer specimens. Breast Cancer Res Treat 2002, 71:95-102.
48. Xu J-M, Song S-T, Tang Z-M, Jiang Z-F, Liu X-Q, Zhang J, Liu X-W: Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat 1999, 53:77-85.